283 related articles for article (PubMed ID: 8239508)
1. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types.
Prins J; De Vries EG; Mulder NH
Anticancer Res; 1993; 13(5A):1373-85. PubMed ID: 8239508
[TBL] [Abstract][Full Text] [Related]
2. Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines.
van Waardenburg RC; Meijer C; Pinto-Sietsma SJ; de Vries EG; Timens W; Mulder NM
Anticancer Res; 1998; 18(1A):91-5. PubMed ID: 9568061
[TBL] [Abstract][Full Text] [Related]
3. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
[TBL] [Abstract][Full Text] [Related]
4. Role of myc amplification and overexpression in cell growth, differentiation and death.
Koskinen PJ; Alitalo K
Semin Cancer Biol; 1993 Feb; 4(1):3-12. PubMed ID: 8448376
[TBL] [Abstract][Full Text] [Related]
5. Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines.
Van Waardenburg RC; Prins J; Meijer C; Uges DR; De Vries EG; Mulder NH
Anticancer Res; 1996; 16(4A):1963-70. PubMed ID: 8712728
[TBL] [Abstract][Full Text] [Related]
6. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
[TBL] [Abstract][Full Text] [Related]
7. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G
Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of the clusterin gene by Ha-ras and c-myc oncogenes and during apoptosis.
Klock G; Storch S; Rickert J; Gutacker C; Koch-Brandt C
J Cell Physiol; 1998 Dec; 177(4):593-605. PubMed ID: 10092212
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the activation of the myc family oncogene and of its stability over time in xenografted human lung carcinomas.
Gazzeri S; Brambilla E; Chauvin C; Jacrot M; Benabid AL; Brambilla C
Cancer Res; 1990 Mar; 50(5):1566-70. PubMed ID: 2154327
[TBL] [Abstract][Full Text] [Related]
10. Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells.
Bar-Ner M; Messing LT; Cultraro CM; Birrer MJ; Segal S
Cell Growth Differ; 1992 Mar; 3(3):183-90. PubMed ID: 1633109
[TBL] [Abstract][Full Text] [Related]
11. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
12. Sequence of a germ-line N-myc gene and amplification as a mechanism of activation.
Ibson JM; Rabbitts PH
Oncogene; 1988 Apr; 2(4):399-402. PubMed ID: 2834684
[TBL] [Abstract][Full Text] [Related]
13. Regulation of C-myc and C-Ha-ras oncogene expression by cell shape.
Farrell RE; Greene JJ
J Cell Physiol; 1992 Nov; 153(2):429-35. PubMed ID: 1385453
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal deletion, gene amplification, alternative processing, and autocrine growth factor production in the pathogenesis of human lung cancer.
Minna JD; Battey JF; Birrer M; Brooks BJ; Cuttitta F; DeGreve J; Gazdar AF; Johnson BE; Nau MM; Sausville EA
Princess Takamatsu Symp; 1986; 17():109-22. PubMed ID: 3332004
[TBL] [Abstract][Full Text] [Related]
15. Myc family of cellular oncogenes.
DePinho R; Mitsock L; Hatton K; Ferrier P; Zimmerman K; Legouy E; Tesfaye A; Collum R; Yancopoulos G; Nisen P
J Cell Biochem; 1987 Apr; 33(4):257-66. PubMed ID: 3034933
[TBL] [Abstract][Full Text] [Related]
16. Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer.
Saksela K; Bergh J; Lehto VP; Nilsson K; Alitalo K
Cancer Res; 1985 Apr; 45(4):1823-7. PubMed ID: 2983887
[TBL] [Abstract][Full Text] [Related]
17. Reduction of c-myc expression by an antisense approach under Cre/loxP switching induces apoptosis in human liver cancer cells.
Ebinuma H; Saito H; Kosuga M; Wakabayashi K; Saito Y; Takagi T; Nakamoto N; Okuyama T; Ishii H
J Cell Physiol; 2001 Jul; 188(1):56-66. PubMed ID: 11382922
[TBL] [Abstract][Full Text] [Related]
18. Antisense inhibition of single copy N-myc expression results in decreased cell growth without reduction of c-myc protein in a neuroepithelioma cell line.
Rosolen A; Whitesell L; Ikegaki N; Kennett RH; Neckers LM
Cancer Res; 1990 Oct; 50(19):6316-22. PubMed ID: 2205380
[TBL] [Abstract][Full Text] [Related]
19. Coexpression pattern of c-myc associated genes in a small cell lung cancer cell line with high steady state c-myc transcription.
Dooley S; Wundrack I; Blin N; Welter C
Biochem Biophys Res Commun; 1995 Aug; 213(3):789-95. PubMed ID: 7654239
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
Wang Z; Ge L; Wang M; Carr BI
J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
